Assessing Markey Cancer Center's Alignment with National Standards for Survivorship Care

Grants and Contracts Details

Description

PROJECT SUMMARY/ABSTRACT This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT- CA-24-032. This administrative supplement application pertains to the National Cancer Institute (NCI) P30 Cancer Center Support Grant that supports the Markey Cancer Center (MCC), a university-based matrix cancer center at the University of Kentucky (UK). The mission of MCC is to reduce cancer burden through research, prevention, treatment, education and community engagement, with a focus on Kentucky and its most vulnerable populations. As the only NCI-designated Comprehensive Cancer Center in the state, MCC is vital to Kentucky, the state which leads the nation in all-site cancer incidence and mortality. MCC aims to translate scientific discoveries into innovative and personalized diagnostic and treatment advances that improve the lives of cancer survivors. Consistent with MCC’s goal to provide exceptional patient-centered, outcome-driven cancer care that exceeds expectations of cancer survivors and caregivers alike, MCC employs advanced practice providers who deliver survivorship care. NOT-CA-24-032 provides a perfect opportunity to examine the quality of MCC survivorship care and take initial steps toward improvement and expansion. The specific aims of the administrative supplement are: 1) Describe the degree to which MCC survivorship care meets the National Standards for Survivorship Care; 2) Identify MCC cancer survivor and caregiver-reported barriers and facilitators to accessing MCC survivorship care and explore differences based on survivors’ treatment phase, disease stage, and geographic residence; and 3) Ascertain promising implementation strategies to improve the quality, reach, adoption, and effectiveness of MCC survivorship care. To accomplish these specific aims, a concurrent mixed- methods study that is guided by the Practical Robust Implementation and Sustainability Model and includes multiple stakeholders (specifically, MCC providers, administrators, advisory group members, survivors and caregivers) as participants will be conducted during the 1-year award period. With unique research strengths and a firm commitment to quality cancer care, MCC is well-poised to generate robust data that will improve the survivorship care it provides.
StatusActive
Effective start/end date7/8/136/30/28

Funding

  • National Cancer Institute

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.